Works by Branche, Angela
Results: 34
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00693-z
- By:
- Publication type:
- Article
Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 5, p. e1007, doi. 10.1093/infdis/jiae424
- By:
- Publication type:
- Article
Real-life Assessment of BioFire FilmArray Pneumonia Panel in Adults Hospitalized With Respiratory Illness.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 214, doi. 10.1093/infdis/jiad221
- By:
- Publication type:
- Article
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 12, p. 1662, doi. 10.1093/infdis/jiad323
- By:
- Publication type:
- Article
The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 3, p. 381, doi. 10.1093/infdis/jiac068
- By:
- Publication type:
- Article
Gene Expression Risk Scores for COVID-19 Illness Severity.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 3, p. 322, doi. 10.1093/infdis/jiab568
- By:
- Publication type:
- Article
Perturbations in Respiratory Syncytial Virus (RSV) Activity During the SARS-CoV-2 Pandemic.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 83, doi. 10.1093/infdis/jiac434
- By:
- Publication type:
- Article
Histoplasmosis Associated With Bat Guano Exposure in Cannabis Growers: 2 Cases.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 12, p. 1, doi. 10.1093/ofid/ofae711
- By:
- Publication type:
- Article
2737. Comparison of Antibody Responses to Vaccination with a Pure Hemagglutinin Influenza Vaccine (rHA) and Licensed Subvirion Influenza Vaccine Made in Eggs or Cell Culture in Adults 60 Years and Older.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S963, doi. 10.1093/ofid/ofz360.2415
- By:
- Publication type:
- Article
2315. The Relationship of Pre-Hospital Functional Status and Clinical Outcomes in Patients with Laboratory-Confirmed RSV Infection: Active Population-Based Surveillance, 2017–2019.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S794, doi. 10.1093/ofid/ofz360.1993
- By:
- Publication type:
- Article
92. Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017–2019.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S7, doi. 10.1093/ofid/ofz359.016
- By:
- Publication type:
- Article
Viral Diagnostics: Only Half the Battle.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials.
- Published in:
- Age & Ageing, 2021, v. 50, n. 5, p. 1546, doi. 10.1093/ageing/afab078
- By:
- Publication type:
- Article
Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152986
- By:
- Publication type:
- Article
Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals.
- Published in:
- Pathogens, 2022, v. 11, n. 2, p. 186, doi. 10.3390/pathogens11020186
- By:
- Publication type:
- Article
A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.
- Published in:
- Infectious Diseases & Therapy, 2025, v. 14, n. 1, p. 39, doi. 10.1007/s40121-024-01081-3
- By:
- Publication type:
- Article
Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem.
- Published in:
- Drugs & Aging, 2015, v. 32, n. 4, p. 261, doi. 10.1007/s40266-015-0258-9
- By:
- Publication type:
- Article
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2323349, doi. 10.1001/jamanetworkopen.2023.23349
- By:
- Publication type:
- Article
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
- Published in:
- Clinical Infectious Diseases, 2025, v. 80, n. 1, p. 223, doi. 10.1093/cid/ciae465
- By:
- Publication type:
- Article
We Have Effective Respiratory Syncytial Virus Vaccines to Prevent Disease in Adults: What Else Do We Need to Know About How to Use Them?
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 1099, doi. 10.1093/cid/ciae362
- By:
- Publication type:
- Article
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 560, doi. 10.1093/cid/ciad209
- By:
- Publication type:
- Article
Effect of Oral Streptococci Expressing Pneumococcus-like Cross-Reactive Capsule Types on World Health Organization Recommended Pneumococcal Carriage Detection Procedure.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 4, p. 647, doi. 10.1093/cid/ciab1003
- By:
- Publication type:
- Article
Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017–2020.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1004, doi. 10.1093/cid/ciab595
- By:
- Publication type:
- Article
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein–Based Influenza Vaccines During the 2017–2018 Season.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 6, p. 1447, doi. 10.1093/cid/ciz996
- By:
- Publication type:
- Article
Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 3, p. 388, doi. 10.1093/cid/ciy917
- By:
- Publication type:
- Article
Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 2, p. 204, doi. 10.1093/cid/ciy880
- By:
- Publication type:
- Article
Impact of Age and Comorbid Conditions on Incidence Rates of COVID‐19‐Associated Hospitalizations, 2020–2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70016
- By:
- Publication type:
- Article
Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis.
- Published in:
- Influenza & Other Respiratory Viruses, 2023, v. 17, n. 1, p. 1, doi. 10.1111/irv.13031
- By:
- Publication type:
- Article
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 6, p. 1151, doi. 10.1111/irv.13043
- By:
- Publication type:
- Article
Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 1, p. 151, doi. 10.1111/irv.12912
- By:
- Publication type:
- Article
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 883, doi. 10.3390/vaccines12080883
- By:
- Publication type:
- Article
Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18465-x
- By:
- Publication type:
- Article